Skip to main content

Table 2 Characteristics of non sentinel node and sentinel node

From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

  Number Percent
NSLNs Examined
Median (range) 15 (11–52)  
N° of positive NSLNs 610 40.8
Median (range) 2 (1–41)
N° of Copies (Highest copy number)
  ≤ 1500 305 20.4
  > 1500–12,000 329 22.0
  > 12,000–111,000 460 30.8
  > 111,000 401 26.8